ArticleJAMA cardiology2025
Automated Deep Learning Phenotyping of Tricuspid Regurgitation in Echocardiography.
Article in JAMA cardiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- "Diagnostic Performance of Artificial Intelligence in Evaluating Tricuspid Regurgitation: A Systematic Review and Meta-Analysis".Clinical cardiology · 2026Pooled it
- Unimodal to multimodal: a systematic review of predictive machine learning models for valvular heart diseases.Frontiers in cardiovascular medicine · 2026Pooled it
- A Multitask Deep Learning Model for Pediatric Echocardiography Analysis.Circulation · 2026Article
- Reinventing the echocardiography workflow: from manual quantification to artificial intelligence-driven comprehensive interpretation.Journal of cardiovascular imaging · 2026Review
- Prognostic Modeling of Tricuspid Valve Regurgitation Outcomes Using Machine Learning-Based Survival Analysis.Journal of clinical medicine · 2026Article
- Clinical Applications of Artificial Intelligence in Structural Heart Disease.Journal of the Society for Cardiovascular Angiography & Interventions · 2026Review
- Automated Classification of Mitral and Tricuspid Regurgitation With Explainability and Real-World Practice Experience.Journal of the American Heart Association · 2026Article
- Automated Phenotyping of Mitral Stenosis Using Deep Learning.medRxiv : the preprint server for health sciences · 2026Article
- Article
- The Emerging Role of Artificial Intelligence in the Assessment of Valvular Heart Disease with Cardiac Imaging.Current cardiology reports · 2026Review
- EACVI Survey on the Current Multi-Modality Imaging Practice in Patients with Tricuspid Regurgitation.European heart journal. Imaging methods and practice · 2026Article
- Evaluation and Management Principles for Chronic Right Heart Failure and Tricuspid Regurgitation.Current heart failure reports · 2025Review
- Comprehensive aortic stenosis characterization using multi-view deep learning.medRxiv : the preprint server for health sciences · 2025Article
- Right Ventricular Dynamics in Tricuspid Regurgitation: Insights into Reverse Remodeling and Outcome Prediction Post Transcatheter Valve Intervention.International journal of molecular sciences · 2025Review
- AI assisted focused cardiac ultrasound in preventive cardiology - a perspective.NPJ cardiovascular health · 2025Review
- Artificial intelligence assessment of valvular disease and ventricular function by a single echocardiography view.Frontiers in digital health · 2025Article
- Artificial Intelligence in Cardiovascular Imaging: Current Applications and New Horizons.Journal of cardiovascular echographyReview
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Importance: Accurate assessment of tricuspid regurgitation (TR) is necessary for identification and risk stratification. Objective: To design a deep learning computer vision workflow for identifying color Doppler echocardiogram videos and characterizing TR severity. Design, Setting, and Participants: An automated deep learning workflow was developed using 47 312 studies (2 079 898 videos) from Cedars-Sinai Medical Center (CSMC) between 2011 and 2021. Data analysis was performed in 2024. The pipeline was tested on a temporally distinct test set of 2462 studies (108 138 videos) obtained in 2022 at CSMC and a geographically distinct cohort of 5549 studies (278 377 videos) from Stanford Healthcare (SHC). Training and validation cohorts contained data from 31 708 patients at CSMC receiving care between 2011 and 2021. Patients were chosen for parity across TR severity classes, with no exclusion criteria based on other clinical or demographic characteristics. The 2022 CSMC test cohort and SHC test cohorts contained studies from 2170 patients and 5014 patients, respectively. Exposure: Deep learning computer vision model. Main Outcomes and Measures: The main outcomes were area under the receiver operating characteristic curve (AUC), sensitivity, and specificity in identifying apical 4-chamber (A4C) videos with color Doppler across the tricuspid valve and AUC in identifying studies with moderate to severe or severe TR. Results: In the CSMC test dataset, the view classifier demonstrated an AUC of 1.000 (95% CI, 0.999-1.000) and identified at least 1 A4C video with color Doppler across the tricuspid valve in 2410 of 2462 studies with a sensitivity of 0.975 (95% CI, 0.968-0.982) and a specificity of 1.000 (95% CI, 1.000-1.000). In the CSMC test cohort, moderate or severe TR was detected with an AUC of 0.928 (95% CI, 0.913-0.943), and severe TR was detected with an AUC of 0.956 (95% CI, 0.940-0.969). In the SHC cohort, the view classifier correctly identified at least 1 TR color Doppler video in 5268 of the 5549 studies, resulting in an AUC of 0.999 (95% CI, 0.998-0.999), a sensitivity of 0.949 (95% CI, 0.944-0.955), and a specificity of 0.999 (95% CI, 0.999-0.999). The artificial intelligence model detected moderate or severe TR with an AUC of 0.951 (95% CI, 0.938-0.962) and severe TR with an AUC of 0.980 (95% CI, 0.966-0.988). Conclusions and Relevance: In this study, an automated pipeline was developed to identify clinically significant TR with excellent performance. With open-source code and weights, this project can serve as the foundation for future prospective evaluation of artificial intelligence-assisted workflows in echocardiography.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.